Clinical pharmacology in the geriatric patient

被引:201
作者
Hilmer, Sarah N. [1 ]
McLachlan, Andrew J.
Le Couteur, David G.
机构
[1] Royal N Shore Hosp, Dept Clin Pharmacol, St Leonards, NSW 2065, Australia
[2] Royal N Shore Hosp, Dept Aged Care, St Leonards, NSW 2065, Australia
[3] Royal N Shore Hosp, Dept Rehabil Med, St Leonards, NSW 2065, Australia
[4] Univ Sydney, St Leonards, NSW 2065, Australia
[5] Concord RG Hosp, CERA, Concord, NSW 2139, Australia
[6] Univ Sydney, Concord, NSW 2139, Australia
[7] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
关键词
adverse drug reactions; clinical pharmacology; evidence-based medicine; geriatric medicine;
D O I
10.1111/j.1472-8206.2007.00473.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Geriatric patients are a subset of older people with multiple comorbidities that usually have significant functional implications. Geriatric patients have impaired homeostasis and wide inter-individual variability. Comprehensive geriatric assessment captures the complexity of the problems that characterize frail older patients and can be used to guide management, including prescribing. Prescribing for geriatric patients requires an understanding of the efficacy of the medication in frail older people, assessment of the risk of adverse drug events, discussion of the harm:benefit ratio with the patient, a decision about the dose regime and careful monitoring of the patient's response. This requires evaluation of evidence from clinical trials, application of the evidence to frail older people through an understanding of changes in pharmacokinetics and pharmacodynamics, and attention to medication management issues. Given that most disease occurs in older people, and that older people are the major recipients of drug therapy in the Western world, increased research and a better evidence base is essential to guide clinicians who manage geriatric patients.
引用
收藏
页码:217 / 230
页数:14
相关论文
共 163 条
[31]   Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis [J].
Choudhry, NK ;
Anderson, GM ;
Laupacis, A ;
Ross-Degnan, D ;
Normand, SLT ;
Soumerai, SB .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7534) :141-143
[32]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[33]   Complementary and alternative medicine (CAM) use by older adults: A comparison of self-report and physician chart documentation [J].
Cohen, RJ ;
Ek, K ;
Pan, CX .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2002, 57 (04) :M223-M227
[34]   The influence of age and sex on the clearance of cytochrome P450 3A substrates [J].
Cotreau, MM ;
von Moltke, LL ;
Greenblatt, DJ .
CLINICAL PHARMACOKINETICS, 2005, 44 (01) :33-60
[35]  
Crotty Maria, 2004, Am J Geriatr Pharmacother, V2, P257, DOI 10.1016/j.amjopharm.2005.01.001
[36]   Epidemiology of medication-related falls and fractures in the elderly [J].
Cumming, RG .
DRUGS & AGING, 1998, 12 (01) :43-53
[37]   Benzodiazepines and risk of hip fractures in older people - A review of the evidence [J].
Cumming, RG ;
Le Couteur, DG .
CNS DRUGS, 2003, 17 (11) :825-837
[38]   Epidemiology of hip fractures [J].
Cumming, RG ;
Nevitt, MC ;
Cummings, SR .
EPIDEMIOLOGIC REVIEWS, 1997, 19 (02) :244-257
[39]   Efficacy, safety and tolerability of β-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure [J].
Deedwania, PC ;
Gottlieb, S ;
Ghali, JK ;
Waagstein, F ;
Wikstrand, JCM .
EUROPEAN HEART JOURNAL, 2004, 25 (15) :1300-1309
[40]   Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic [J].
Dergal, JM ;
Gold, JL ;
Laxer, DA ;
Lee, MSW ;
Binns, MA ;
Lanctôt, KL ;
Freedman, M ;
Rochon, PA .
DRUGS & AGING, 2002, 19 (11) :879-886